cefuroxime has been researched along with Pneumococcal Infections in 36 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Pneumococcal Infections: Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 9.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "The comparative efficacies of amoxicillin and cefuroxime against acute otitis media caused by a penicillin-resistant (MIC, 2 micrograms/ml) Streptococcus pneumoniae strain were assessed in a gerbil model by challenging each ear with 10(7) bacteria through transbullar instillation." | 7.70 | In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 1998) |
| "Amoxicillin, cefpodoxime and cefuroxime MICs remained low against numerous penicillin resistant strains, indicating that these three oral antibiotics (in combination with clavulanate for amoxicillin) have a useful potential for the treatment of acute otitis media when risk factors for pneumococcal penicillin-resistant infections are detected." | 7.70 | [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]. ( Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C, 1998) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 5.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| "A series of patients aged 3 months to 15 years who fulfilled strict criteria for bacterial pneumonia, other respiratory infections, sepsis-like infections, and other acute infections were prospectively randomized to receive parenteral penicillin or cefuroxime randomly for 4 or 7 days." | 5.09 | Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. ( Kallio, MJ; Peltola, H; Vuori-Holopainen, E, 2001) |
| " pneumoniae is associated with an impaired bacteriologic and clinical response of acute otitis media to cefaclor and cefuroxime axetil." | 5.08 | Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. ( Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P, 1996) |
| "The comparative efficacies of amoxicillin and cefuroxime against acute otitis media caused by a penicillin-resistant (MIC, 2 micrograms/ml) Streptococcus pneumoniae strain were assessed in a gerbil model by challenging each ear with 10(7) bacteria through transbullar instillation." | 3.70 | In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 1998) |
| "Amoxicillin, cefpodoxime and cefuroxime MICs remained low against numerous penicillin resistant strains, indicating that these three oral antibiotics (in combination with clavulanate for amoxicillin) have a useful potential for the treatment of acute otitis media when risk factors for pneumococcal penicillin-resistant infections are detected." | 3.70 | [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]. ( Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C, 1998) |
| "The efficacy of amoxicillin/clavulanate and cefuroxime was determined in a gerbil model of otitis media with a mixed Streptococcus pneumoniae plus Haemophilus influenzae middle ear (ME) infection." | 3.70 | Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 2000) |
| "Eighty-four children suffering from acute otitis media caused by Streptococcus pneumoniae were treated prospectively with cefuroxime axetil suspension (30 mg/kg of body weight twice daily for 8 days)." | 3.69 | In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. ( Berche, P; Gehanno, P; Lenoir, G, 1995) |
| "The antimicrobial spectrum of cefuroxime, an antibiotic of the cephalosporin family was studied in vitro with respect to 11 species (16 strains) of gram-positive and gram-negative bacteria and in vivo on albino mice with experimental salmonellosis or pneumococcal infections." | 3.66 | [Experimental study of the antibiotic activity of cefuroxime]. ( Bil'ko, IP; Ginzburg, TS; Mil'chenko, KP; Sokalo, SV, 1982) |
| " The population was characterized by a population pharmacokinetic model, and distributions of CLcr and body weight were reflective of the target group." | 1.35 | Estimation of cefuroxime dosage using pharmacodynamic targets, MIC distributions, and minimization of a risk function. ( Cars, O; Jönsson, S; Karlsson, MO; Viberg, A, 2008) |
| "Infants and children with pneumococcal infections cared for at eight children's hospitals." | 1.31 | Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. ( Barson, WJ; Bradley, JS; Givner, LB; Kaplan, SL; Kim, KS; Mason, EO; Schutze, GE; Tan, TQ; Wald, ER; Yogev, R, 2001) |
| "Amoxicillin was by far the most effective antibiotic when considering its intrinsic activity (96% of the PRSP inhibited at 2 mg/l), the inhibitory quotient (100% of the PRSP > 1 vs 69." | 1.30 | Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae. ( Goldstein, FW, 1997) |
| "Ampicillin + gentamicin was significantly superior to gentamicin alone but not to ampicillin alone." | 1.27 | Interaction between beta-lactam antibiotics and gentamicin against Streptococcus pneumoniae in vitro and in vivo. ( Frimodt-Møller, N; Frølund Thomsen, V, 1987) |
| "Treatment with cefuroxime appears to be a safe and effective therapy for pediatric soft-tissue infections due to H influenzae and S pneumoniae." | 1.27 | Cefuroxime therapy for bacteremic soft-tissue infections in children. ( Barson, WJ; Brady, MT; Hribar, MM; Marcon, MJ; Miller, MA; Pacini, DL; Powell, DA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.89) | 18.7374 |
| 1990's | 16 (44.44) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 3 (8.33) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Gamil, A | 1 |
| Chokephaibulkit, K | 1 |
| Phongsamart, W | 1 |
| Techasaensiri, C | 1 |
| Piralam, B | 1 |
| Thamaree, R | 1 |
| Chen, KJ | 1 |
| Chong, YJ | 1 |
| Sun, MH | 1 |
| Chen, HC | 1 |
| Liu, L | 1 |
| Chen, YP | 1 |
| Wu, WC | 1 |
| Kang, EY | 1 |
| Lai, CC | 1 |
| Torumkuney, D | 1 |
| Zemlickova, H | 1 |
| Maruscak, M | 1 |
| Morrissey, I | 1 |
| Al-Mazrou, KA | 1 |
| Shibl, AM | 2 |
| Kandeil, W | 1 |
| Pirçon, JY | 1 |
| Marano, C | 1 |
| Burton, C | 1 |
| Walls, T | 1 |
| Price, N | 1 |
| Glasgow, T | 1 |
| Walker, C | 1 |
| Beasley, S | 1 |
| Best, E | 1 |
| Viberg, A | 1 |
| Cars, O | 1 |
| Karlsson, MO | 1 |
| Jönsson, S | 1 |
| Neuhauser, MM | 1 |
| Prause, JL | 1 |
| Danziger, LH | 1 |
| Pendland, SL | 1 |
| Marrie, TJ | 1 |
| Peltola, V | 1 |
| Svedström, E | 1 |
| Waris, M | 1 |
| Heikkinen, T | 1 |
| Ruuskanen, O | 1 |
| Bil'ko, IP | 1 |
| Mil'chenko, KP | 1 |
| Ginzburg, TS | 1 |
| Sokalo, SV | 1 |
| Gehanno, P | 1 |
| Lenoir, G | 1 |
| Berche, P | 1 |
| Lopardo, HA | 1 |
| Lovadina, L | 1 |
| Rubeglio, EA | 1 |
| Krisher, KK | 1 |
| Linscott, A | 1 |
| Paniara, O | 1 |
| Platsouka, E | 1 |
| Dimopoulou, H | 1 |
| Constantoulaki, S | 1 |
| Skedros, DG | 1 |
| Haddad, J | 1 |
| Bluestone, CD | 1 |
| Curtin, HD | 1 |
| Dagan, R | 1 |
| Abramson, O | 1 |
| Leibovitz, E | 1 |
| Lang, R | 1 |
| Goshen, S | 1 |
| Greenberg, D | 1 |
| Yagupsky, P | 1 |
| Leiberman, A | 1 |
| Fliss, DM | 1 |
| Waites, K | 1 |
| Swiatlo, E | 1 |
| Gray, B | 1 |
| Brookings, E | 1 |
| Goldstein, FW | 1 |
| Verhaegen, J | 1 |
| Verbist, L | 1 |
| Cenjor, C | 2 |
| Ponte, C | 2 |
| Parra, A | 2 |
| Nieto, E | 2 |
| García-Calvo, G | 2 |
| Giménez, MJ | 3 |
| Aguilar, L | 4 |
| Soriano, F | 2 |
| Geslin, P | 2 |
| Fremaux, A | 1 |
| Sissia, G | 1 |
| Spicq, C | 1 |
| Georges, S | 1 |
| Lontie, M | 1 |
| Liekens, K | 1 |
| Deschilder, I | 1 |
| Baquero, F | 1 |
| García-Rodríguez, JA | 1 |
| García de Lomas, J | 1 |
| Williams-Bouyer, N | 1 |
| Hernandez, A | 1 |
| Reisner, BS | 1 |
| Zuck, P | 1 |
| Petitpretz, P | 1 |
| Rio, Y | 1 |
| Leblanc, F | 1 |
| Al Rasheed, AM | 1 |
| Elbashier, AM | 1 |
| Osoba, AO | 1 |
| Oliver, A | 1 |
| Sabán, J | 1 |
| Pujol, I | 1 |
| Peromingo, R | 1 |
| Tarragó, D | 1 |
| Galindo, J | 1 |
| Meseguer, MA | 1 |
| Peltola, H | 1 |
| Vuori-Holopainen, E | 1 |
| Kallio, MJ | 1 |
| Pérez-Trallero, E | 1 |
| Alkorta, M | 1 |
| Vicente, D | 1 |
| Kaplan, SL | 1 |
| Mason, EO | 1 |
| Barson, WJ | 2 |
| Tan, TQ | 1 |
| Schutze, GE | 1 |
| Bradley, JS | 1 |
| Givner, LB | 1 |
| Kim, KS | 1 |
| Yogev, R | 1 |
| Wald, ER | 1 |
| Singh, KP | 1 |
| Voolmann, T | 1 |
| Lang, SD | 1 |
| Henderson, FW | 1 |
| Gilligan, PH | 1 |
| Wait, K | 1 |
| Goff, DA | 1 |
| Frimodt-Møller, N | 2 |
| Frølund Thomsen, V | 1 |
| Bentzon, MW | 1 |
| Thomsen, VF | 1 |
| Miller, MA | 1 |
| Marcon, MJ | 1 |
| Hribar, MM | 1 |
| Brady, MT | 1 |
| Pacini, DL | 1 |
| Powell, DA | 1 |
1 review available for cefuroxime and Pneumococcal Infections
| Article | Year |
|---|---|
Pneumococcal disease in Thailand.
Topics: Anti-Bacterial Agents; Cefuroxime; Cost of Illness; Cost-Benefit Analysis; Drug Resistance, Multiple | 2021 |
4 trials available for cefuroxime and Pneumococcal Infections
| Article | Year |
|---|---|
Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Azi | 2004 |
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Drug Re | 1996 |
Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefixime; Cefuroxime; Cephalosporins; Chronic Disease; D | 1999 |
Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study.
Topics: Adolescent; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Female; Humans; Infant; Male; | 2001 |
31 other studies available for cefuroxime and Pneumococcal Infections
| Article | Year |
|---|---|
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; C | 2021 |
Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Community-Acquired Infections; Czech Rep | 2018 |
A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Child, Preschool; Drug Resistance, Mul | 2014 |
Paediatric empyema in New Zealand: a tale of two cities.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefuro | 2015 |
Estimation of cefuroxime dosage using pharmacodynamic targets, MIC distributions, and minimization of a risk function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Creatinine; Drug Admi | 2008 |
In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Culture Media; Drug Thera | 2003 |
Pulmonary abscess of viral-bacterial etiology in a neonate.
Topics: Anti-Infective Agents; Cefuroxime; Cephalexin; Escherichia coli Infections; Female; Humans; Infant, | 2007 |
[Experimental study of the antibiotic activity of cefuroxime].
Topics: Animals; Bacteria; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; In Vitro Techniques; Mi | 1982 |
In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
Topics: Acute Disease; Cefuroxime; Child, Preschool; Humans; Infant; Microbial Sensitivity Tests; Otitis Med | 1995 |
More about cefuroxime screening test for pneumococci.
Topics: Cefuroxime; Cephalosporin Resistance; Child; Data Interpretation, Statistical; Diagnostic Errors; Ev | 1995 |
Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae.
Topics: Cefotaxime; Cefuroxime; Cephalosporin Resistance; Humans; Microbial Sensitivity Tests; Penicillin Re | 1994 |
In vitro evaluation of cefodizime, cefuroxime, ceftriaxone against respiratory pathogens.
Topics: Cefotaxime; Ceftriaxone; Cefuroxime; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsie | 1994 |
Subperiosteal orbital abscess in children: diagnosis, microbiology, and management.
Topics: Abscess; Adolescent; Bacteria; Cefuroxime; Child; Child, Preschool; Ethmoid Sinus; Female; Haemophil | 1993 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefproz | 1997 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxi | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cef | 1998 |
In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media.
Topics: Acute Disease; Amoxicillin; Animals; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; | 1998 |
[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
Topics: Acute Disease; Amoxicillin; beta-Lactam Resistance; beta-Lactams; Cefpodoxime; Ceftizoxime; Cefuroxi | 1998 |
In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefurox | 1998 |
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.
Topics: Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Penicil | 1999 |
Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
Topics: Cefotaxime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Evaluation Studies as To | 1999 |
Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefuroxime; Cephalosporins; C | 2000 |
Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Clarithromycin; Humans; | 2000 |
Pneumococcal psoas abscess: report of two cases.
Topics: Cefotaxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumococcal Infections; | 2000 |
Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
Topics: Amoxicillin; Animals; Area Under Curve; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Diseas | 2001 |
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Ce | 2001 |
Pneumococcal bacteraemia in south Auckland: a five year review with emphasis on prescribing practices.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Cefuroxi | 1992 |
Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care.
Topics: Amoxicillin; Carrier State; Cefuroxime; Child Day Care Centers; Child, Preschool; Drug Combinations; | 1988 |
Interaction between beta-lactam antibiotics and gentamicin against Streptococcus pneumoniae in vitro and in vivo.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefuroxime; Drug Synergism; Drug Therapy, Combination; F | 1987 |
Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone.
Topics: Animals; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Female; Mice; Microbial Sensitivity Te | 1987 |
Cefuroxime therapy for bacteremic soft-tissue infections in children.
Topics: beta-Lactamases; Cefuroxime; Cellulitis; Cephalosporins; Child, Preschool; Drug Resistance, Microbia | 1985 |